129 related articles for article (PubMed ID: 16219151)
1. [Selective expansion of human natural killer cells].
Peng BG; Liang LJ; He Q; Li J; Lu MD
Ai Zheng; 2005 Oct; 24(10):1287-9. PubMed ID: 16219151
[TBL] [Abstract][Full Text] [Related]
2. Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma.
Peng BG; Liang LJ; He Q; Huang JF; Lu MD
World J Gastroenterol; 2004 Jul; 10(14):2119-23. PubMed ID: 15237448
[TBL] [Abstract][Full Text] [Related]
3. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
[TBL] [Abstract][Full Text] [Related]
4. Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.
Harada H; Saijo K; Watanabe S; Tsuboi K; Nose T; Ishiwata I; Ohno T
Jpn J Cancer Res; 2002 Mar; 93(3):313-9. PubMed ID: 11927014
[TBL] [Abstract][Full Text] [Related]
5. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
[TBL] [Abstract][Full Text] [Related]
6. Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer.
Oikawa T; Kawai K; Ishiwata I; Ohno T; Akaza H
BJU Int; 2003 Dec; 92(9):1009-15. PubMed ID: 14632866
[TBL] [Abstract][Full Text] [Related]
7. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
[TBL] [Abstract][Full Text] [Related]
8. A GFP-transfected HFWT cell line, GHINK-1, as a novel target for non-RI activated natural killer cytotoxicity assay.
Harada H; Saijo K; Ishiwata I; Ohno T
Hum Cell; 2004 Mar; 17(1):43-8. PubMed ID: 15369136
[TBL] [Abstract][Full Text] [Related]
9. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.
Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
Hum Immunol; 2001 Oct; 62(10):1092-8. PubMed ID: 11600215
[TBL] [Abstract][Full Text] [Related]
10. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
11. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
12. Augmenting the expression of NKp44 molecule and the natural killer activity in peripheral blood mononuclear cells from patients with malignant colorectal carcinoma.
Sheikhi A; Saadati K; Jafarzadeh A; Karimi H; Mousavinasab N
Drug Res (Stuttg); 2014 Jun; 64(6):281-6. PubMed ID: 24154937
[TBL] [Abstract][Full Text] [Related]
13. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21.
Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W
Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS
Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
Lim SA; Kim TJ; Lee JE; Sonn CH; Kim K; Kim J; Choi JG; Choi IK; Yun CO; Kim JH; Yee C; Kumar V; Lee KM
Cancer Res; 2013 Apr; 73(8):2598-607. PubMed ID: 23580577
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
Masuyama J; Murakami T; Iwamoto S; Fujita S
Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
[TBL] [Abstract][Full Text] [Related]
17. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expansion of natural killer cells for clinical applications.
Klingemann HG; Martinson J
Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo activation of CD56(+) immune cells that eradicate neuroblastoma.
Rujkijyanont P; Chan WK; Eldridge PW; Lockey T; Holladay M; Rooney B; Davidoff AM; Leung W; Vong Q
Cancer Res; 2013 Apr; 73(8):2608-18. PubMed ID: 23440424
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
